Shaanxi Kanghui Pharmaceutical's IPO

Shaanxi Kanghui Pharmaceutical raised a round of funding on April 21, 2017. Investors include Public.

Shaanxi Kanghui Pharmaceutical (康惠制药) (SH: 603139) researches, develops, produces, and sells pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respi…

Articles about Shaanxi Kanghui Pharmaceutical's IPO: